Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
|
Medicamen Biotech
|
Kilitch Drugs(India)
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.49 % | 4.81 % | 23.02 % |
|
5yr average Equity Multiplier
|
1.47 | 1.42 | 1.16 |
|
5yr Average Asset Turnover Ratio
|
0.58 | 0.51 | 0.69 |
|
5yr Avg Net Profit Margin
|
10.0 % | 6.07 % | 28.95 % |
|
Price to Book
|
2.69 | 2.98 | 6.41 |
|
P/E
|
68.91 | 28.93 | 34.55 |
|
5yr Avg Cash Conversion Cycle
|
13.14 Days | -7.56 Days | 57.55 Days |
|
Inventory Days
|
66.66 Days | 17.9 Days | 26.01 Days |
|
Days Receivable
|
122.66 Days | 138.92 Days | 50.74 Days |
|
Days Payable
|
257.34 Days | 193.35 Days | 75.73 Days |
|
5yr Average Interest Coverage Ratio
|
10.36 | 5.07 | 75.33 |
|
5yr Avg ROCE
|
12.12 % | 8.16 % | 30.18 % |
|
5yr Avg Operating Profit Margin
|
16.84 % | 9.07 % | 36.73 % |
|
5 yr average Debt to Equity
|
0.14 | 0.14 | 0.02 |
|
5yr CAGR Net Profit
|
-6.51 % | 77.02 % | 17.49 % |
|
5yr Average Return on Assets
|
5.75 % | 3.38 % | 19.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.16 % | 69.23 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.44 % | 0.98 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medicamen Biotech
|
Kilitch Drugs(India)
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|